As glo bal clinical development becomes more complex, China continues to play a critical role in scientific innovation, patient diversity, and biotech growth. Sponsors conducting global and multi regional clinical trials increasingly require partners who can operate with local precision while maintaining global consistency. To support this demand, Precision for Medicine has expanded its footprint in Greater China. Encompassing Mainland China, Hong Kong, and Taiwan, each with distinct regulatory